PolyPid Ltd (POLY):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:PolyPid Ltd (POLY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8200
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PolyPid Ltd (PolyPid) is a pharmaceutical company that develops manufactures and commercializes therapies for the treatment of various medical conditions including infection, pain, inflammation and cancer. The company’s pipeline product candidates include D-Plex100, an antibiotic drug reservoir that is implanted during surgery to prevent and treat surgical site infections; D-PLEX1000, a product candidate used in orthopedic surgeries for the prevention of surgical site infections and support of bone recovery; and D-PLEX500 for use in periodontal and oral or maxillofacial surgeries to treat peri-implantitis. It develops its products using polymer-lipid encapsulation matrix technology. The company collaborates with pharmaceutical and biotechnology companies through licensing and collaboration agreements for the encapsulation of their drugs including peptides, proteins and antibodies. PolyPid is headquartered in Petach Tikva, Israel.

PolyPid Ltd (POLY) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PolyPid Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PolyPid Ltd, Medical Devices Deals, 2012 to YTD 2018 9
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PolyPid Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
PolyPid Raises US$2.4 Million In Third Round Of Financing 11
PolyPid Raises US$2 Million In Second Round Of Financing 12
Equity Offering 13
Polypid to Raise upto USD80 Million in IPO 13
PolyPid Raises USD3.8 Million in Private Placement of Shares 15
PolyPid Raises USD4 Million in Private Placement of Shares 16
PolyPid Ltd – Key Competitors 17
PolyPid Ltd – Key Employees 18
PolyPid Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Clinical Trials 20
Dec 21, 2017: PolyPid Appoints Jacob Harel as Chairman of the Board of Directors 20
Aug 16, 2017: PolyPid Completes Enrollment in Phase Ib/II Study of D-PLEX in Post-Cardiac Surgery Sternal Infection 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
PolyPid Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PolyPid Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PolyPid Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
PolyPid Ltd, Medical Devices Deals, 2012 to YTD 2018 9
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
PolyPid Raises US$2.4 Million In Third Round Of Financing 11
PolyPid Raises US$2 Million In Second Round Of Financing 12
Polypid to Raise upto USD80 Million in IPO 13
PolyPid Raises USD3.8 Million in Private Placement of Shares 15
PolyPid Raises USD4 Million in Private Placement of Shares 16
PolyPid Ltd, Key Competitors 17
PolyPid Ltd, Key Employees 18
PolyPid Ltd, Subsidiaries 19

List of Figures
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
PolyPid Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
PolyPid Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[PolyPid Ltd (POLY):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emzor Pharmaceutical Industries Ltd:企業の戦略的SWOT分析
    Emzor Pharmaceutical Industries Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • ON Semiconductor Corp (ON):企業の財務・戦略的SWOT分析
    ON Semiconductor Corp (ON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • EV Energy Partners LP:企業のM&A・事業提携・投資動向
    EV Energy Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EV Energy Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • DeNA Co Ltd (2432):企業の財務・戦略的SWOT分析
    DeNA Co Ltd (2432) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • bet-at-home.com AG (ACX):企業の財務・戦略的SWOT分析
    bet-at-home.com AG (ACX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • 3-D Matrix Inc:企業の戦略的SWOT分析
    3-D Matrix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Pernod Ricard SA (RI):企業の財務・戦略的SWOT分析
    Pernod Ricard SA (RI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Nestle (Malaysia) Bhd:企業の戦略・SWOT・財務情報
    Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report Summary Nestle (Malaysia) Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Xintela AB (XINT):企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also p …
  • Biogen, Inc.:企業のM&A・事業提携・投資動向
    Biogen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Biogen, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Gran Tierra Energy Inc (GTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Gran Tierra Energy Inc (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia. It sells oil t …
  • Apex Biotechnology Corp (1733):医療機器:M&Aディール及び事業提携情報
    Summary Apex Biotechnology Corp (ApexBio) is a medical device company that develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company provides patient self-testing products, point of care diagnostics and multi-functional products. It also imports and expo …
  • Welspun Corp Ltd:企業の戦略・SWOT・財務情報
    Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Welspun Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Manitou BF SA:企業の戦略・SWOT・財務情報
    Manitou BF SA - Strategy, SWOT and Corporate Finance Report Summary Manitou BF SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • OncoSil Medical Ltd (OSL)-医療機器分野:企業M&A・提携分析
    Summary OncoSil Medical Ltd (OncoSil), formerly NeuroDiscovery Ltd is a medical device company that develops and commercializes treatments for patients with pancreatic and liver cancer. The company’s lead product include oncosil, a brachytherapy device that emits beta radiation and is implanted dire …
  • EllisDon Corporation:企業の戦略・SWOT・財務情報
    EllisDon Corporation - Strategy, SWOT and Corporate Finance Report Summary EllisDon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • UNeMed Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Unemed Corp (Unemed), a subsidiary of University of Nebraska Medical Center, is a healthcare service provider. The company offers services such as inventions, material transfer, confidentiality, intellectual property, startup formation and licensing process. Its technologies include therapeu …
  • Takeuchi Mfg. Co Ltd
    Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Syncardia Systems LLC:企業の戦略的SWOT分析
    Syncardia Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PharmAust Ltd (PAA):企業の財務・戦略的SWOT分析
    Summary PharmAust Ltd (PAA) is a clinical-stage company that focuses on the development of targeted cancer therapeutics for the treatment of human and veterinary cancers. The company’s lead product candidate Monepantel is a small molecule that has been developed to treat parasite infections in food …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆